Editorial: Bioresponsive nanomaterials for drug delivery or controlled release

• Yan Pan,
• Kezhen Qi,
• Jijun Fu,
• Wei Gao,
• Zhao Li,
• Zhiqiang Lin

Affiliations

Yan Pan

Department of Pharmacology, Institute of Systems Biomedicine, Beijing Key Laboratory of Tumor Systems Biology, School of Basic Medical Sciences, Peking University, Beijing, China

Kezhen Qi

College of Pharmacy, Dali University, Dali, Yunnan, China

Jijun Fu

Key Laboratory of Molecular Target and Clinical Pharmacology, School of Pharmaceutical Sciences, The First Affiliated Hospital of Guangzhou Medical University and the Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China

Wei Gao

Department of Pharmaceutical Sciences, College of Pharmacy, Rogel Cancer Center, University of MI, Ann Arbor, MI, United States

Zhao Li

Department of Hepatobiliary Surgery, Peking University People’s Hospital, Beijing, China

Zhiqiang Lin

Department of Pharmacology, Institute of Systems Biomedicine, Beijing Key Laboratory of Tumor Systems Biology, School of Basic Medical Sciences, Peking University, Beijing, China